Suzhou Basecare Medical's (HKG:2170) subsidiary Genea Biomedx agreed to cooperate with Rhea Labs to establish model artificial intelligence-powered in vitro fertilization clinics.
The five-year strategic cooperation will see the parties jointly expand the assisted reproductive industry markets across the US, Europe, South America, and Southeast Asia, a Tuesday bourse filing said.
Under the tie-up, Genea Biomedx will provide medical products and comprehensive solutions to support the development of Rhea Labs' reproductive institutions and jointly collaborate to develop AI-powered new products.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。